The role of Fas ligand in vivo as a cause and regulator of pathogenesis
- 1 June 2000
- journal article
- review article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 12 (3) , 330-335
- https://doi.org/10.1016/s0952-7915(00)00095-9
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute (CA28533, RG2835, AI07163)
- Multiple Sclerosis Society (CA28533, RG2835, AI07163)
- National Institute of Allergy and Infectious Diseases (CA28533, RG2835, AI07163)
This publication has 36 references indexed in Scilit:
- Fas/Fas ligand on the road: an apoptotic pathway common to AIDS, autoimmunity, lymphoproliferation and transplantationMedical Hypotheses, 1999
- TUMOR NECROSIS FACTOR RECEPTOR AND Fas SIGNALING MECHANISMSAnnual Review of Immunology, 1999
- MATURE T LYMPHOCYTE APOPTOSIS—Immune Regulation in a Dynamic and Unpredictable Antigenic EnvironmentAnnual Review of Immunology, 1999
- CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+T cellsNature, 1995
- Dominant interfering fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndromeCell, 1995
- Activation-induced death of mature T cells in the regulation of immune responsesCurrent Opinion in Immunology, 1995
- Generalized lymphoproliferative disease in mice, caused by a point mutation in the fas ligandCell, 1994
- Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor familyCell, 1993
- Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosisNature, 1992
- Lpr and gld: Single Gene Models of Systemic Autoimmunity and Lymphoproliferative DiseaseAnnual Review of Immunology, 1991